![Steven Bloom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Bloom
Corporate Officer/Principal bei
WEREWOLF THERAPEUTICS, INC.
Profil
Steven Bloom is currently Chief Business Officer at Werewolf Therapeutics, Inc. Former positions include Sales Director at Vavotar Life Sciences LLC, Principal at Eli Lilly & Co., Global Vice President-Marketing at PAREXEL International Corp., Chief Business Officer & Vice President at Transgene SA, Vice President-Sales at PharMetrics, Inc., Principal at the University of Rhode Island, Senior VP-Government & Industry Affairs at Alaunos Therapeutics, Inc. from 2012 to 2014, Chief Strategy Officer at Verastem, Inc. from 2017 to 2019, Senior Vice President at Boston Pharmaceuticals, Inc., and Chief Business Officer at Vincerx Pharma, Inc. Education includes undergraduate studies at Northeastern University.
Aktive Positionen von Steven Bloom
| Unternehmen | Position | Beginn |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Corporate Officer/Principal | 17.04.2025 |
Ehemalige bekannte Positionen von Steven Bloom
| Unternehmen | Position | Ende |
|---|---|---|
| VERASTEM, INC. | Corporate Officer/Principal | 01.04.2019 |
| ALAUNOS THERAPEUTICS, INC. | General Counsel | 01.03.2014 |
| VINCERX PHARMA, INC. | Corporate Officer/Principal | - |
Vavotar Life Sciences LLC
 Vavotar Life Sciences LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Vertrieb & Marketing | - |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Corporate Officer/Principal | - |
Ausbildung von Steven Bloom
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
38
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
PharMetrics, Inc.
 PharMetrics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare market insights based on longitudinal and patient-centric information | Commercial Services |
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Vavotar Life Sciences LLC
Vavotar Life Sciences LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Vincerx Pharma, Inc.
 Vincerx Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to address cancer | Health Technology |
